Cargando…
Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13 years after denileukin diftitox
Autores principales: | Lewis, Daniel J., Dao, Harry, Nagarajan, Priyadharsini, Duvic, Madeleine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5728491/ https://www.ncbi.nlm.nih.gov/pubmed/29296637 http://dx.doi.org/10.1016/j.jdcr.2017.06.031 |
Ejemplares similares
-
Successful Treatment of Primary Cutaneous Anaplastic Large Cell Lymphoma with Denileukin Diftitox
por: Amagai, Mayuko, et al.
Publicado: (2022) -
Denileukin diftitox for the treatment of cutaneous T-cell lymphoma
por: Kaminetzky, David, et al.
Publicado: (2008) -
Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T-cell lymphoma
por: Lansigan, Frederick, et al.
Publicado: (2010) -
Advanced-Stage Primary Cutaneous T-Cell Lymphoma Treated with Bexarotene and Denileukin Diftitox
por: Cervigón-González, Iván, et al.
Publicado: (2011) -
Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and Sézary syndrome
por: Prince, H. Miles, et al.
Publicado: (2013)